KKR offered to buy the shares in Biotage that it doesn't already own in a deal that values the Swedish life sciences company at $1.2 billion. The U.S. investment firm said it can provide the capital ...

Roche plans to invest $50 billion in the U.S. over the next five years, joining Swiss rival Novartis in expanding its footprint in the country amid President Trump's tariff threats.

Nomura Holdings plans to buy Macquarie Group's public asset management business in the U.S. and Europe for $1.8 billion in a bid to strengthen its investment management business, even amid volatile ...

Shares of JD.com and Meituan slumped on Tuesday as intensifying competition in China's food-delivery market fuels concerns about thinning margins and near-term profitability. Both JD.com and Meituan ...

Stocks dropped on Monday, with the Morningstar US Market Index closing down 2.4% after President Donald Trump continued his ...

The Italian government said Friday that it imposed conditions in connection with UniCredit's offer for Banco BPM to protect strategic interests for national security, but didn't specify them. Its ...

A sharp decline in the U.S. dollar over the past few weeks has captivated Wall Street, and inspired a wave of catastrophizing about the end of the dollar's reign as the de facto global reserve ...

We assign a narrow moat rating for Alibaba Health due to its network effect from the number of healthcare merchants, pharmacies, and online doctors on its platform, and intangible assets that come ...

The EV maker is set to report its first-quarter results on Tuesday. New CEO Lip-Bu Tan's first earnings call with Wall Street is later this week. Analysts see next week's "Foundry Day" as a bigger ...

The new duties imposed by the Trump administration apply to several companies in Southeast Asia. Some producers in Cambodia face tariffs of more than 3,500%. That comes at a challenging time for the ...

Gain insight on Comerica, Meiji Yasuda Life Insurance and more in the latest Market Talks covering Financial Services.

Last week's oil rally petered out as U.S. talks over Iran's nuclear program opened the door to an eventual easing of sanctions against Iranian crude, while U.S.-China trade tensions kept demand ...